Long-term disability and progression in spinal onset multiple sclerosis. 2018

Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
Department of Neurology, TCSB Izmir Tepecik Education and Research Hospital, Gaziler caddesi No: 468, Yenisehir, Konak, 35170, Izmir, Turkey. irem.tiftikcioglu@gmail.com.

The aim of this study is to investigate the long-term effects of the initial spinal cord (SC) involvement in MS patients. In this retrospective, single-center study, 824 patients with definite MS were screened. A total of 348 patients were excluded for ambiguous documentation of the initial relapse, pediatric onset, diagnosis of primary progressive disease, irregular assessments or visits causing doubt on the onset of progression time, and clinical follow-up duration less than 12 months. Eventually, 476 MS patients were included. Data regarding the demographics, initial symptoms, the degree of recovery from the initial relapse, neuroimaging, cerebrospinal fluid analysis, long-term disability, and progression were collected from the medical registry. The mean duration of follow-up was 7.49 ± 5.30 years. The percentage of patients entering the progressive disease course was 23.3 in the whole group. A total of 157 patients (33.0%) had SC involvement during the first clinical relapse. These patients were significantly older at disease onset (31.69 ± 10.18 vs. 29.55 ± 9.49; p = 0.028), had higher rates of progression (32.5 vs. 18.8%; p = 0.001), and had higher disability scores in long-term follow-up (3.41 ± 2.19 vs. 2.62 ± 1.81; p < 0.001). Mean age at the transition of progressive phase was 41.4 ± 11.2 years. The degree of recovery from the initial relapse significantly affected the long-term disability. The poor recovery from the initial relapse was associated with older onset age and higher EDSS scores. Being older than 40 years during MS onset and poor recovery from the initial relapse exerted an increased risk for progression. The initial SC involvement was related to a more severe relapse with less chance of complete recovery and higher risk for progression. Confirmation of risk factors in different MS cohorts would increase our understanding of the complex disease mechanisms.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D005260 Female Females
D006233 Disabled Persons Persons with physical or mental disabilities that affect or limit their activities of daily living and that may require special accommodations. Handicapped,People with Disabilities,Persons with Disabilities,Physically Challenged,Physically Handicapped,Physically Disabled,Disabilities, People with,Disabilities, Persons with,Disability, Persons with,Disabled Person,Disabled, Physically,Handicapped, Physically,People with Disability,Person, Disabled,Persons with Disability,Persons, Disabled
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013116 Spinal Cord A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER. Coccygeal Cord,Conus Medullaris,Conus Terminalis,Lumbar Cord,Medulla Spinalis,Myelon,Sacral Cord,Thoracic Cord,Coccygeal Cords,Conus Medullari,Conus Terminali,Cord, Coccygeal,Cord, Lumbar,Cord, Sacral,Cord, Spinal,Cord, Thoracic,Cords, Coccygeal,Cords, Lumbar,Cords, Sacral,Cords, Spinal,Cords, Thoracic,Lumbar Cords,Medulla Spinali,Medullari, Conus,Medullaris, Conus,Myelons,Sacral Cords,Spinal Cords,Spinali, Medulla,Spinalis, Medulla,Terminali, Conus,Terminalis, Conus,Thoracic Cords
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
June 2019, Neurology,
Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
November 2010, Radiology,
Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
July 2016, Annals of neurology,
Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
March 2023, Multiple sclerosis (Houndmills, Basingstoke, England),
Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
September 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research,
Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
November 2017, Brain : a journal of neurology,
Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
May 2020, Journal of clinical medicine,
Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
January 2012, Multiple sclerosis (Houndmills, Basingstoke, England),
Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
May 2013, JAMA neurology,
Bedile Irem Tiftikcioglu, and Irem Ilgezdi, and Yasar Zorlu, and Ufuk Sener, and Figen Tokucoglu
October 2022, Multiple sclerosis (Houndmills, Basingstoke, England),
Copied contents to your clipboard!